2-Morpholin-4-yl-benzaldehyde, 95.0%, 1g

1-Bromo-4-[(difluoromethyl)sulfanyl]benzene, 97%, 25g

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-5-(DIMETHYLAMINO)-5-OXOPENTANOIC ACID, 95.0%, 500mg

Lead(II) Acetate [for Perovskite precursor]>98.0%(T)5g

4'-Hydroxyazobenzene-2-carboxylic Acid [Matrix for MALDI-TOF/MS]>98.0%(HPLC)(T)1g

4-Chloro-6-piperazin-1-yl-pyrimidine hydrochloride, 95.0%, 1g

Ethyl 3-(3-methoxyphenyl)propanoate, 95+%, 1g

1-(2-Chlorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 97.0%, 1g

Guanabenz acetate, 98.0%, 1g

1-Butyl-3-phenylthiourea, 100mg

3-chloro-N-(4-ethoxyphenyl)propanamide, 95.0%, 1g

(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]100mg

2-Methyl-2-(methyltellanyl)propanenitrile>95.0%(GC)100mg